BioSerenity

BioSerenity is a medical device company focused on developing smart healthcare solutions.

BioSerenity solutions combine wearable textiles with embedded sensors, mobile technology and a cloud-based solution for doctors to remotely access data.

BioSerenity was founded in 2013 by Pierre-Yves Frouin. The company is based in Paris, France with additional offiices in 5. TROYES (FR), LYON (FR), BOSTON (MA), ATLANTA (GA), and SHENZHEN (CHI).

BioSerenity is the first of its kind to develop a system of epileptic diagnosis that you can wear.

BioSerenity's first product is the Neuronaute, a mobile EEG system using smart clothing that allows for long term monitoring of EEG signals in order to help with the diagnosis of epilepsy. They are now working on Cardiology, Urology, Sleep Disorders and Pregnancy Monitoring.

 

BioSerenity has developped a Cloud platform that allows us to deploy Medical Device and Mobile Apps powered with A.I. around the World.

 

BioSerenity is backed by investors including Bpifrance, Idinvest Partners, Dassault Systemes, Kurma Partners, & LBO France among others. The company raised € 65M in it's latest round of "Series B" funding on Jun 19, 2019. This brings BioSerenity's total funding to € 83M.

 

 

  • Year founded: 2013
  • Funding Info: € 83M in 3 Funding Rounds (Last Funding Type: Series B)
  • Yearly Revenue: $5M-$10M (2018)
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Paris
  • State: Paris
  • Country: France
Related businesses